Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Abstract
Highly potent, but poorly water-soluble, drug candidates are common outcomes of contemporary drug discovery programmes and present a number of challenges to drug development - most notably, the issue of reduced systemic exposure after oral administration. However, it is increasingly apparent that formulations containing natural and/or synthetic lipids present a viable means for enhancing the oral bioavailability of some poorly water-soluble, highly lipophilic drugs. This Review details the mechanisms by which lipids and lipidic excipients affect the oral absorption of lipophilic drugs and provides a perspective on the possible future applications of lipid-based delivery systems. Particular emphasis has been placed on the capacity of lipids to enhance drug solubilization in the intestinal milieu, recruit intestinal lymphatic drug transport (and thereby reduce first-pass drug metabolism) and alter enterocyte-based drug transport and disposition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conventional absorption and bioavailability assessments, and the body-weight regressions built upon them, implicitly assume the portal route and seldom quantify the lymphatic contribution, even though, for suitable compounds, it can represent a substantial fraction of systemic exposure [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“This route becomes quantitatively relevant only for compounds that combine high lipophilicity with appreciable long-chain triglyceride solubility, for which a log P greater than 5 and a lipid solubility above approximately 50 mg/g are commonly cited as approximate thresholds [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“Because lymphatic delivery reaches the systemic circulation while bypassing hepatic first-pass metabolism, it can materially increase the oral bioavailability of affected compounds and lower their apparent first-pass loss in a manner that a body-weight regression of systemic clearance or volume cannot anticipate [28,29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“For highly lipophilic drugs, a fraction of the absorbed dose can bypass the portal circulation entirely and reach the systemic circulation via the intestinal lymphatics, associated with triglyceride-rich lipoproteins (chylomicrons) assembled within the enterocyte [28,29].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“The extent of transport is highly sensitive to prandial state and to the type and quantity of co-administered lipid, which differ across preclinical study designs and between the fasted conditions typical of first-in-human protocols and the fed conditions under which lymphatic transport is greatest [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734 · cited 1×
“This is especially the case when potent, but highly lipophilic, drug candidates arise from complex chemical scaffolds and multiple high-throughput activity screen”
BackgroundNuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Apolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836
Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J., Kwiterovich, P., Shan, B., Barnes, R., & Hobbs, H. H. (2000) · Science · doi:10.1126/science.290.5497.1771 · Cited by 1,648
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,577
Smit, J. J. M., Schinkel, A. H., Elferink, R. P. J. O., Groen, A. K., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., Ottenhoff, R., van der Lugt, N. M. T., van Roon, M. A., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90380-9 · Cited by 1,456
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401 · cited 1×
“In addition to the potential effect of lipidic excipients (primarily surfactants) on P-gp-mediated efflux, Benet and co-workers have recently suggested that high-fat meals could inhibit P-g”
BackgroundSelf-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
Neslihan Gursoy, R., & Benita, S. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.02.001 · Cited by 1,358
Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers
Repa, J. J., Turley, S. D., Lobaccaro, J.-M. A., Medina, J., Li, L., Lustig, K., Shan, B., Heyman, R. A., Dietschy, J. M., & Mangelsdorf, D. J. (2000) · Science · doi:10.1126/science.289.5484.1524 · Cited by 1,301
Cited by
McClements, D. J., & Rao, J. (2011) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.559558 · Cited by 1,630
“Lipid digestion also depends on the molecular characteristics of digestible triacylglycerols oils, eg, medium-chain triglycerides (MCT) tend to be digested more rapidly than long-chain triglycerides (corn oil) ( Porter et al, 2007 ).”
BackgroundStrategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
“Lymphatic drug transport has been described for many highly lipophilic drugs and has been the subject of several reviews (Porter and Charman, 2001b; O’Driscoll, 2002; Porter et al., 2007; Trevaskis et al., 2008; Yanez et al., 2011).”
BackgroundMethodInfluentialSelf-citationNanoemulsion: Concepts, development and applications in drug delivery
Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.008 · Cited by 1,358
“Drugs which enter mesenteric lymph are directly transported to systemic circulation without undergoing hepatic first pass metabolism[92].”
BackgroundBiomedical Applications of Supramolecular Systems Based on Host–Guest Interactions
Ma, X., & Zhao, Y. (2015) · Chemical Reviews · doi:10.1021/cr500392w · Cited by 1,225
McClements, D. J., & Li, Y. (2010) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2010.06.010 · Cited by 905
Pouton, C. W., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.010 · Cited by 885
Self-citationAdvances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
Bioavailability and Delivery of Nutraceuticals Using Nanotechnology
Huang, Q., Yu, H., & Ru, Q. (2010) · Journal of Food Science · doi:10.1111/j.1750-3841.2009.01457.x · Cited by 793
Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An Update
Jantratid, E., Janssen, N., Reppas, C., & Dressman, J. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9569-4 · Cited by 764
“(27) were applied to generate compositions of biorelevant media more representative of the fasted and fed conditions in”
BackgroundMethodEnhancing intestinal drug solubilisation using lipid-based delivery systems
Porter, C. J. H., Pouton, C. W., Cuine, J. F., & Charman, W. N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.014 · Cited by 690
Self-citationNanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules
Tamjidi, F., Shahedi, M., Varshosaz, J., & Nasirpour, A. (2013) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2013.03.002 · Cited by 689
Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview
Friesen, D. T., Shanker, R., Crew, M., Smithey, D. T., Curatolo, W. J., & Nightingale, J. A. S. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8000793 · Cited by 610
Kraft, J. C., Freeling, J. P., Wang, Z., & Ho, R. J. Y. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23773 · Cited by 606
The influence of emulsion structure and stability on lipid digestion
Golding, M., & Wooster, T. J. (2010) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2009.11.006 · Cited by 592
Nanoemulsion- and emulsion-based delivery systems for curcumin: Encapsulation and release properties
Ahmed, K., Li, Y., McClements, D. J., & Xiao, H. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2011.11.039 · Cited by 586
Oral lipid-based drug delivery systems – an overview
Kalepu, S., Manthina, M., & Padavala, V. (2013) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.10.001 · Cited by 494
Review of in vitro digestion models for rapid screening of emulsion-based systems
McClements, D. J., & Li, Y. (2010) · Food & Function · doi:10.1039/c0fo00111b · Cited by 464
The Use of Biorelevant Dissolution Media to Forecast the In Vivo Performance of a Drug
Klein, S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9203-3 · Cited by 458
“Therefore, updated compositions of biorelevant dissolution media, based on the physiological parameters recently summarized in the literature (62,63), were presented by Jantratid et al.”
MethodMa, D., Hettiarachchi, G., Nguyen, D., Zhang, B., Wittenberg, J. B., Zavalij, P. Y., Briken, V., & Isaacs, L. (2012) · Nature Chemistry · doi:10.1038/nchem.1326 · Cited by 451
McClements, D. J. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.02.002 · Cited by 449
“For example, mixedmicelles are capable of solubilizing FFAs, MAGs, and some nutraceuticals [64].”
BackgroundLipid-Based Delivery Systems and Intestinal Lymphatic Drug Transport: A Mechanistic Update
Trevaskis, N. L., Charman, W. N., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.007 · Cited by 442
“Indeed the efficiency of lipid digestion and solubilisation in the intestinal lumen (reviewed elsewhere in this issue and previously [5,6,30]) and subsequent uptake and transport across intestinal absorptive cells is likely to significantly influence the access of lipophilic drugs to the lymph.”
BackgroundSelf-citationCustodio, J. M., Wu, C.-Y., & Benet, L. Z. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.043 · Cited by 434
Ganesan, P., & Narayanasamy, D. (2017) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2017.07.002 · Cited by 434
Improving the Oral Bioavailability of Curcumin Using Novel Organogel-Based Nanoemulsions
Yu, H., & Huang, Q. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf300609p · Cited by 429
50 years of oral lipid-based formulations: provenance, progress and future perspectives
Feeney, O. M., Crum, M. F., McEvoy, C. L., Trevaskis, N. L., Williams, H. D., Pouton, C. W., Charman, W. N., Bergström, C. A. S., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.007 · Cited by 426
Self-citationLi, Y., & McClements, D. J. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf101325m · Cited by 418
Ostertag, F., Weiss, J., & McClements, D. J. (2012) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2012.07.089 · Cited by 414
Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability
Kohli, K., Chopra, S., Dhar, D., Arora, S., & Khar, R. K. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.007 · Cited by 411
Lipid – An emerging platform for oral delivery of drugs with poor bioavailability
Chakraborty, S., Shukla, D., Mishra, B., & Singh, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.001 · Cited by 411
Shan, W., Zhu, X., Liu, M., Li, L., Zhong, J., Sun, W., Zhang, Z., & Huang, Y. (2015) · ACS Nano · doi:10.1021/acsnano.5b00028 · Cited by 395
Approaches for the development of solid and semi-solid lipid-based formulations
Jannin, V., Musakhanian, J., & Marchaud, D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.006 · Cited by 388
The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.003 · Cited by 385
Self-citationIntestinal permeation enhancers for oral peptide delivery
Maher, S., Mrsny, R. J., & Brayden, D. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.005 · Cited by 381
“16mM in the fed state [160], although one would expect such loss of efficacy to be reduced at in vivo PE dose levels above their CMC, as free monomer concentration”
BackgroundIn vitro models for the prediction of in vivo performance of oral dosage forms
Kostewicz, E. S., Abrahamsson, B., Brewster, M., Brouwers, J., Butler, J., Carlert, S., Dickinson, P. A., Dressman, J., Holm, R., Klein, S., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.024 · Cited by 373
“Figure 6: Schematic representation of dissolution stress test apparatus Figure 7: An example of a lipolysis model (adapted from Porter et al., 2007) Figure 8: TIM-1 system (A. stomach compartment; B. pyloric sphincter; C. duodenum compartment; D. peristaltic valve; E. jejunum compartment; F.…”
BackgroundBoyd, B. J., Bergström, C. A. S., Vinarov, Z., Kuentz, M., Brouwers, J., Augustijns, P., Brandl, M., Bernkop-Schnürch, A., Shrestha, N., Préat, V., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.104967 · Cited by 367
McClements, D. J. (2012) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2012.03.002 · Cited by 346
Dahan, A., & Hoffman, A. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.021 · Cited by 341
Li, Y., Hu, M., & McClements, D. J. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2010.11.027 · Cited by 339
“This effect can be attributed to the fact that the medium chain FFA digestion products arising from MCT have a higher dispersibility in aqueous media than the long chain FFA digestion products arising from corn oil (Porter et al., 2007; Pouton & Porter, 2006).”
BackgroundSelf-microemulsifying drug delivery system (SMEDDS) – challenges and road ahead
Dokania, S., & Joshi, A. K. (2015) · Drug Delivery · doi:10.3109/10717544.2014.896058 · Cited by 337
“Increasing the viscosity of the aqueous medium decreases the rate of drug diffusion from bulk solution to the crystal nuclei or surface, inhibiting crystallization, during both nucleation and growth phases (Porter et al., 2007).”
BackgroundPotential biological fate of ingested nanoemulsions: Influence of particle characteristics
McClements, D. J., & Xiao, H. (2012) · Food Funct. · doi:10.1039/c1fo10193e · Cited by 331
Ozturk, B., Argin, S., Ozilgen, M., & McClements, D. J. (2015) · Food Chemistry · doi:10.1016/j.foodchem.2015.04.065 · Cited by 329
Lipid-based formulations for oral administration of poorly water-soluble drugs
Mu, H., Holm, R., & Müllertz, A. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.054 · Cited by 328
“…with focus on self-emulsifying delivery 65 system (SEDDS) and assessment of lipid-based formulations using in vitro lipolysis (Porter et al.,2008), and provided a good overview on lipid digestion and drug solubilisation in the small intestine as well as lymphatic transport (Porter et al.,2007).”
BackgroundMethodTing, Y., Jiang, Y., Ho, C.-T., & Huang, Q. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2013.12.010 · Cited by 327
Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
Fricker, G., Kromp, T., Wendel, A., Blume, A., Zirkel, J., Rebmann, H., Setzer, C., Quinkert, R.-O., Martin, F., & Müller-Goymann, C. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0130-x · Cited by 326
“GI-tract and their impact on drug absorption, see (9,74).”
BackgroundMcClements, D. J. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.08.004 · Cited by 322
Lymphatic System in Cardiovascular Medicine
Aspelund, A., Robciuc, M. R., Karaman, S., Makinen, T., & Alitalo, K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306544 · Cited by 321
“increase the oral bioavailability of rapidly liver-metabolized drugs.(46) Below, we discuss aspects of lymphatic development,”
BackgroundPreparation and evaluation of self-microemulsifying drug delivery system of oridonin
Zhang, P., Liu, Y., Feng, N., & Xu, J. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.026 · Cited by 316
“The lipid composition of SMEDDS may be related to facilitate the extent of lymphatic drug transport by stimulating lipoprotein formation and intestinal lymphatic liquid flux (Iwanaga et al., 2006; Porter et al., 2007).”
BackgroundPBPK models for the prediction of in vivo performance of oral dosage forms
Kostewicz, E. S., Aarons, L., Bergstrand, M., Bolger, M. B., Galetin, A., Hatley, O., Jamei, M., Lloyd, R., Pepin, X., Rostami-Hodjegan, A., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.09.008 · Cited by 315
“SolBiorel Solaq ScaqxMWt ¼ SRxCbile ð4Þ Bile salt concentrations in individual gut compartments in fasted and fed state can be calculated based on published values for human, rat, and dog (Porter et al., 2007; Sugano, 2009a).”
MethodMcClements, D. J., Li, F., & Xiao, H. (2015) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-032814-014043 · Cited by 315
Katouzian, I., Faridi Esfanjani, A., Jafari, S. M., & Akhavan, S. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.07.017 · Cited by 311
Hur, S. J., Decker, E. A., & McClements, D. J. (2009) · Food Chemistry · doi:10.1016/j.foodchem.2008.09.069 · Cited by 309
Intestinal permeability and its relevance for absorption and elimination
Lennernäs, H. (2007) · Xenobiotica · doi:10.1080/00498250701704819 · Cited by 304
“An improved understanding of drug membrane transport in the small and large intestine in humans is vital to the development of new and effective oral pharmaceutical products (Ungell et al. 1998; Wilding et al. 2000; Davis and Wilding 2001; Brayden 2003; Lindahl et al. 2004; Lennernas and Abrahamsson 2005; Petri et al.…”
BackgroundLipid-Based Drug Delivery Systems
Shrestha, H., Bala, R., & Arora, S. (2014) · Journal of Pharmaceutics · doi:10.1155/2014/801820 · Cited by 304
Dima, C., Assadpour, E., Dima, S., & Jafari, S. M. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12547 · Cited by 302
Buya, A. B., Beloqui, A., Memvanga, P. B., & Préat, V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121194 · Cited by 301
“As the oil content is reduced during the dispersion or digestion, the solubilizing capacity of SNEDDSs declines in vivo, leading to drug precipitation [229].”
BackgroundChoi, S. J., & McClements, D. J. (2020) · Food Science and Biotechnology · doi:10.1007/s10068-019-00731-4 · Cited by 298
O'Driscoll, C. M., & Griffin, B. T. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.012 · Cited by 296
Qi, J., Hu, X., Dong, X., Lu, Y., Lu, H., Zhao, W., & Wu, W. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.009 · Cited by 292
Zhang, X., Xing, H., Zhao, Y., & Ma, Z. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030074 · Cited by 285
“In addition to providing a supersaturated drug concentration in the gastrointestinal tract, lipid formulations have the advantages of motivating intestinal lymphatic drug transport and optimizing enterocyte-based drug transport and disposition whereby to reduce the first-pass effect and increase the lipophilic drug’s…”
BackgroundImpact of gastric structuring on the lipolysis of emulsified lipids
Golding, M., Wooster, T. J., Day, L., Xu, M., Lundin, L., Keogh, J., & Clifton, P. (2011) · Soft Matter · doi:10.1039/c0sm01227k · Cited by 282
Intestinal lymphatic transport for drug delivery
Yáñez, J. A., Wang, S. W. J., Knemeyer, I. W., Wirth, M. A., & Alton, K. B. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.019 · Cited by 278
“Drug transport via the intestinal lymphatics is generally enhanced by an increase in lipid amount [122,175,240].”
BackgroundInfluentialChen, Y., Lu, Y., Chen, J., Lai, J., Sun, J., Hu, F., & Wu, W. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.022 · Cited by 274
Williams, H. D., Sassene, P., Kleberg, K., Bakala-N'Goma, J.-C., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., Jule, E., et al. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23205 · Cited by 274
Self-citationWang, R., Zhou, L., Wang, W., Li, X., & Zhang, F. (2017) · Nature Communications · doi:10.1038/ncomms14702 · Cited by 272
Wasan, K. M., Brocks, D. R., Lee, S. D., Sachs-Barrable, K., & Thornton, S. J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2353 · Cited by 269
“Incorporation of drugs into chylomicrons capitalizes on the lymphatic route of transport and forms the basis of lymphatic drug deliver”
BackgroundMcClements, D. J. (2020) · Foods · doi:10.3390/foods9040421 · Cited by 260
Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs
Bergström, C. A. S., Holm, R., Jørgensen, S. A., Andersson, S. B. E., Artursson, P., Beato, S., Borde, A., Box, K., Brewster, M., Dressman, J., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.015 · Cited by 257
Amoabediny, G., Haghiralsadat, F., Naderinezhad, S., Helder, M. N., Akhoundi Kharanaghi, E., Mohammadnejad Arough, J., & Zandieh-Doulabi, B. (2018) · International Journal of Polymeric Materials and Polymeric Biomaterials · doi:10.1080/00914037.2017.1332623 · Cited by 256
“Despite great success in the lead optimization program, highly lipophilic drug candidates are the major outcomes of such critical drug discovery drives [1].”
Miller, J. M., Beig, A., Carr, R. A., Spence, J. K., & Dahan, A. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300104s · Cited by 256
Nanoparticle-Based Delivery Systems for Vaccines
Bezbaruah, R., Chavda, V. P., Nongrang, L., Alom, S., Deka, K., Kalita, T., Ali, F., Bhattacharjee, B., & Vora, L. (2022) · Vaccines · doi:10.3390/vaccines10111946 · Cited by 253
Yang, Y., & McClements, D. J. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.03.033 · Cited by 251
“First, medium-chain FFAs have a higher water dispersibility than long-chain FFAs (Porter et al., 2007; Pouton & Porter, 2008).”
BackgroundInfluentialAzman, M., Sabri, A. H., Anjani, Q. K., Mustaffa, M. F., & Hamid, K. A. (2022) · Pharmaceuticals · doi:10.3390/ph15080975 · Cited by 250
“Bile salts are endogenous compounds that are present in the small intestine, with concentrations ranging from 8 mM and 18 mM in the fasted and fed state, respectively [66].”
BackgroundNiu, M., Lu, Y., Hovgaard, L., Guan, P., Tan, Y., Lian, R., Qi, J., & Wu, W. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.02.009 · Cited by 248
“A small fraction of the survived intact liposomes will permeate across the unstirred water layer [39] and be internalized through either the M-cell or the trans-enterocyte pathway.”
BackgroundCharacterization of Human Duodenal Fluids in Fasted and Fed State Conditions
Riethorst, D., Mols, R., Duchateau, G., Tack, J., Brouwers, J., & Augustijns, P. (2016) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24603 · Cited by 245
Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin
He, Z., Santos, J. L., Tian, H., Huang, H., Hu, Y., Liu, L., Leong, K. W., Chen, Y., & Mao, H.-Q. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.03.028 · Cited by 244
“[27, 34] Recently, nanoparticles have been shown as a promising platform for oral delivery of insulin.[35-43] While these reports have shown the feasibility and”
BackgroundGonçalves, R. F. S., Martins, J. T., Duarte, C. M. M., Vicente, A. A., & Pinheiro, A. C. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.06.011 · Cited by 243
Vithani, K., Goyanes, A., Jannin, V., Basit, A. W., Gaisford, S., & Boyd, B. J. (2019) · Pharmaceutical Research · doi:10.1007/s11095-018-2531-1 · Cited by 233
Lymphatic transport of high-density lipoproteins and chylomicrons
Randolph, G. J., & Miller, N. E. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71610 · Cited by 233
“First, drugs engineered to target chy-lomicrons for transport into the lymphatic vasculature might avoid the liver toxicity sometimes associated with higher doses of drugs that are transported through the portal venous vasculature (66).”
Towards applications of bioentities@MOFs in biomedicine
Velásquez-Hernández, M. D. J., Linares-Moreau, M., Astria, E., Carraro, F., Alyami, M. Z., Khashab, N. M., Sumby, C. J., Doonan, C. J., & Falcaro, P. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213651 · Cited by 233
An update on oral drug delivery via intestinal lymphatic transport
Zhang, Z., Lu, Y., Qi, J., & Wu, W. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.022 · Cited by 231
Self-Assembled Structures and p Ka Value of Oleic Acid in Systems of Biological Relevance
Salentinig, S., Sagalowicz, L., & Glatter, O. (2010) · Langmuir · doi:10.1021/la101012a · Cited by 228
Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic
Maher, S., Leonard, T. W., Jacobsen, J., & Brayden, D. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.006 · Cited by 227
“The consensus however, is that dissolved monomeric fatty acids perturb the enterocyte membrane whereas mixedmicelles are not absorbed per se (for review see [195]).”
A Review of Food–Drug Interactions on Oral Drug Absorption
Deng, J., Zhu, X., Chen, Z., Fan, C. H., Kwan, H. S., Wong, C. H., Shek, K. Y., Zuo, Z., & Lam, T. N. (2017) · Drugs · doi:10.1007/s40265-017-0832-z · Cited by 226
“The partitioning of highly lipophilic drugs (LogP[ 5) in the intestinal lumen into the lymph is an alternative absorption pathway into the blood that bypasses first-pass hepatic extraction [101].”
BackgroundReview and analysis of FDA approved drugs using lipid-based formulations
Savla, R., Browne, J., Plassat, V., Wasan, K. M., & Wasan, E. K. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1342654 · Cited by 225
Encapsulation of Ibuprofen in CD-MOF and Related Bioavailability Studies
Hartlieb, K. J., Ferris, D. P., Holcroft, J. M., Kandela, I., Stern, C. L., Nassar, M. S., Botros, Y. Y., & Stoddart, J. F. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00168 · Cited by 225
Čerpnjak, K., Zvonar, A., Gašperlin, M., & Vrečer, F. (2013) · Acta Pharmaceutica · doi:10.2478/acph-2013-0040 · Cited by 224
Nature‐Inspired Design and Application of Lipidic Lyotropic Liquid Crystals
Mezzenga, R., Seddon, J. M., Drummond, C. J., Boyd, B. J., Schröder‐Turk, G. E., & Sagalowicz, L. (2019) · Advanced Materials · doi:10.1002/adma.201900818 · Cited by 223
Gao, F., Zhang, Z., Bu, H., Huang, Y., Gao, Z., Shen, J., Zhao, C., & Li, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.013 · Cited by 219
Thomas, N., Holm, R., Müllertz, A., & Rades, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.027 · Cited by 215
Edible lipid nanoparticles: Digestion, absorption, and potential toxicity
McClements, D. J. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.04.008 · Cited by 215
“The characteristics of lipid nanoparticles may influence this process by altering the solubilization of carrier lipids and lipophilic components within mixed micelles [96,116].”
BackgroundInfluentialMcClements, D. J., & Xiao, H. (2014) · Food Funct. · doi:10.1039/c4fo00100a · Cited by 215
McClements, D. J., Decker, E. A., Park, Y., & Weiss, J. (2008) · Food Biophysics · doi:10.1007/s11483-008-9070-y · Cited by 213
Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations”
Buckley, S. T., Frank, K. J., Fricker, G., & Brandl, M. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.04.002 · Cited by 213
Research progress on liposomes: Application in food, digestion behavior and absorption mechanism
Liu, W., Hou, Y., Jin, Y., Wang, Y., Xu, X., & Han, J. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.08.012 · Cited by 212
Towards Better Delivery of Cannabidiol (CBD)
Millar, S. A., Maguire, R. F., Yates, A. S., & O’Sullivan, S. E. (2020) · Pharmaceuticals · doi:10.3390/ph13090219 · Cited by 212
“This is likely due to increased micelle and chylomicron formation making more drugs available for lymphatic transport [21,22].”
BackgroundDesign of Nano‐Laminated Coatings to Control Bioavailability of Lipophilic Food Components
McClements, D. J. (2010) · Journal of Food Science · doi:10.1111/j.1750-3841.2009.01452.x · Cited by 211
Delivery of Lipophilic Bioactives: Assembly, Disassembly, and Reassembly of Lipid Nanoparticles
Yao, M., Xiao, H., & McClements, D. J. (2014) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-072913-100350 · Cited by 210
“Mixed micelles solubilize lipophilic bioactive components and transport them to the epithelial cells, where they can be absorbed (Porter & Charman 2001a,b,c; Porter et al. 2007).”
BackgroundO'Sullivan, C. M., Barbut, S., & Marangoni, A. G. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.08.018 · Cited by 209
“The manipulation of bioavailability with the addition of lipid as discussed above can also be seen in the design and evaluation of drug delivery materi ls (Humberstone & Charman, 1997; Porter et al., 2007).”
BackgroundMethodInfluentialRecent advances to improve curcumin oral bioavailability
Sabet, S., Rashidinejad, A., Melton, L. D., & McGillivray, D. J. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.02.006 · Cited by 207
Gajda, A. M., & Storch, J. (2015) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.10.001 · Cited by 205
“In the intestine, the hydrolytic products of dietary lipids from the lumen enter the enterocyte from the lumen across the apical side of the cell, while endogenous lipids present in the bloodstream are delivered across the basolateral side [71].”
Background
Metadata
- Authors
- Porter, C. J. H., Trevaskis, N. L., & Charman, W. N.
- Affiliations
- Monash University (AU)
- Corresponding author
- Porter, Christopher J. H.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-03
- Volume
- 6
- Issue
- 3
- Pages
- 231-248
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2069235788
- Cited by
- 1,824
- References
- 253
- Citations by year
- 2026: 88 · 2025: 87 · 2024: 67 · 2023: 89 · 2022: 119 · 2021: 108 · 2020: 140 · 2019: 101 · 2018: 117 · 2017: 121 · 2016: 125 · 2015: 119 · 2014: 120 · 2013: 128 · 2012: 94
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- lipid-based drug delivery, oral bioavailability, lipophilic drugs, poorly water-soluble drugs, lipid excipients, first-pass metabolism, lipid-based formulations
- MeSH terms
- Administration, Oral, Animals, Pharmaceutical Preparations, Excipients, Humans, Intestinal Absorption, Lipids, Drug Design, Drug Delivery Systems, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.